Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Erdheim-Chester disease

Julien Haroche, Fleur Cohen-Aubart, Zahir Amoura

Blood (2020) 135 (16): 1311–1318.

https://doi.org/10.1182/blood.2019002766

Published: 2020

Journal Articles

Concomitant BRAF Mutation in Hairy Cell Leukemia and Papillary Thyroid Cancer

Shehab Mohamed, MD, Mohamed A Yassin, MBBS, MSc, Abdulqadir Jeprel Nashwan, BSN, MSN, RN, CBT-HMS, Halima El Omri, Firyal Ibrahim, MB, CHB, PhD, Susana El akiki, PhD

Blood (2018) 132 (Supplement 1): 5140.

https://doi.org/10.1182/blood-2018-99-116084

Published: 2018

Journal Articles

KRAS , NRAS and BRAF Mutations Are Highly Enriched in TRI12 Chronic Lymphocytic Leukemia and Are Associated to Shorter Time to First Treatment

Elena Vendramini, PhD, Riccardo Bomben, PhD, Federico Pozzo, PhD, Dania Benedetti, PhD, Maria Francesca Rossi, PhD, Michele Dal Bo, PhD, Gabriele Pozzato, MD, Francesco Zaja, MD, Annalisa Chiarenza, MD PhD, Francesco Di Raimondo, MD, Giovanni Del Poeta, MD, Valter Gattei, MD, Antonella Zucchetto

Blood (2018) 132 (Supplement 1): 3113.

https://doi.org/10.1182/blood-2018-99-111864

Published: 2018

Journal Articles

Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults

Paul Milne, Venetia Bigley, Chris M. Bacon, Antoine Néel, Naomi McGovern, Simon Bomken, Muzlifah Haniffa, Eli L. Diamond, Benjamin H. Durham, Johannes Visser, David Hunt, Harsha Gunawardena, Mac Macheta, Kenneth L. McClain, Carl Allen, Omar Abdel-Wahab, Matthew Collin

Blood (2017) 130 (2): 167–175.

https://doi.org/10.1182/blood-2016-12-757823

Published: 2017

Includes: Supplemental data

Journal Articles

Hairy Cell Leukemia Variant Has Similar Survival to Classical Disease Despite Poorer Responses to Initial Therapy: A 30-Year Experience from Memorial Sloan Kettering Cancer Center

Bartlomiej Getta, MBBS,, Kaitlin M Woo, MS, Sean Devlin, PhD, Jae H. Park, MD, Omar Abdel-Wahab, Martin S Tallman, MD

Blood (2015) 126 (23): 1476.

https://doi.org/10.1182/blood.V126.23.1476.1476

Published: 2015

Journal Articles

High prevalence of somatic MAP2K1 mutations in BRAF V600E–negative Langerhans cell histiocytosis

Noah A. Brown, Larissa V. Furtado, Bryan L. Betz, Mark J. Kiel, Helmut C. Weigelin, Megan S. Lim, Kojo S. J. Elenitoba-Johnson

Blood (2014) 124 (10): 1655–1658.

https://doi.org/10.1182/blood-2014-05-577361

Published: 2014

Includes: Supplemental data

Journal Articles

Radioulnar Synostosis-Hematology (RUS-H) Syndrome: Description of the New Syndrome and Comparison to Similar Syndromes

Evangelista E Jessie, BA, Mary M. Ruisi, MD, Daniel Green, MD, Rachel Burt, PhD, Jaclyn Davis, MD, Regina A. Macatangay, MD, Farid Boulad, MD, Shivani Shah, MBBS, Brenda Oiyemhonlan, MD, MPH, MHSA, Benjamin T. Kile, PhD, James B Bussel, MD

Blood (2012) 120 (21): 1100.

https://doi.org/10.1182/blood.V120.21.1100.1100

Published: 2012

Journal Articles

High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses

Blood (2012) 120 (13): 2700–2703.

https://doi.org/10.1182/blood-2012-05-430140

Published: 2012

Journal Articles

BRAF mutation: supporting diversity in HCL

Jan A. Burger

Blood (2012) 119 (14): 3193–3194.

https://doi.org/10.1182/blood-2012-01-403659

Published: 2012

Journal Articles

Frequent BRAF V600E Mutations Are Identified in CD207+ Cells in LCH Lesions, but BRAF Status does not Correlate with Clinical Presentation of Patients or Transcriptional Profiles of CD207+ Cells

Tricia L Peters, MD, MS, Tsz-Kwong Chris Man, PhD, Jeremy Price, Renelle George, Phaik Har Lim, MS, Kenneth Matthew Heym, MD, Miriam Merad, MD, PhD, Kenneth L. McClain, MD, PhD, Carl E Allen, MD, PhD

Blood (2011) 118 (21): 1372.

https://doi.org/10.1182/blood.V118.21.1372.1372

Published: 2011

Journal Articles

Kinase-Inactivating Braf Mutation Drives Aneuploidy In Splenic Myeloid Cells by Deregulation of Craf

Tamihiro Kamata, Susan Giblett, Robert Hayward, Richard Marais, Catrin A Pritchard

Blood (2010) 116 (21): 3138.

https://doi.org/10.1182/blood.V116.21.3138.3138

Published: 2010

Journal Articles

Recurrent BRAF mutations in Langerhans cell histiocytosis

Gayane Badalian-Very, Jo-Anne Vergilio, Barbara A. Degar, Laura E. MacConaill, Barbara Brandner, Monica L. Calicchio, Frank C. Kuo, Azra H. Ligon, Kristen E. Stevenson, Sarah M. Kehoe, Levi A. Garraway, William C. Hahn, Matthew Meyerson, Mark D. Fleming, Barrett J. Rollins

Blood (2010) 116 (11): 1919–1923.

https://doi.org/10.1182/blood-2010-04-279083

Published: 2010

Includes: Supplemental data

Journal Articles

BRAF Mutations in Juvenile Myelomonocytic Leukemia.

Andrica C.H. de Vries, MD, Ronald W. Stam, PhD, Christian Kratz, MD, Martin Zenker, PhD, Oskar A. Haas, MD, Elisabeth van Wering, PhD, Christian M. Zwaan, MD PhD, Franco Locatelli, MD, Marco Zecca, MD, Henrik Hasle, MD, Jan Stary, MD, Charlotte Marie Niemeyer, MD Phd, M.M. Van Den Heuvel, MD PhD

Blood (2007) 110 (11): 4602.

https://doi.org/10.1182/blood.V110.11.4602.4602

Published: 2007

Journal Articles

Role of BRAF Mutations in Hematopoietic Malignancies and the Induction of Cytokine-Independence-Synergy with PI3K/Akt Pathway.

Massimo Libra, MD, Maria C. Mazzarino, MD, Valli De Re, PhD, Linda S. Steelman, MS, Steven L. Abrams, BS, Fred E. Bertrand, PhD, John G. Shelton, PhD, Sarah Molton, PhD, Martin McMahon, PhD, James A. McCubrey, PhD

Blood (2005) 106 (11): 4291.

https://doi.org/10.1182/blood.V106.11.4291.4291

Published: 2005

NARROW

Erdheim-Chester disease

Concomitant BRAF Mutation in Hairy Cell Leukemia and Papillary Thyroid Cancer

KRAS , NRAS and BRAF Mutations Are Highly Enriched in TRI12 Chronic Lymphocytic Leukemia and Are Associated to Shorter Time to First Treatment

Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults

Hairy Cell Leukemia Variant Has Similar Survival to Classical Disease Despite Poorer Responses to Initial Therapy: A 30-Year Experience from Memorial Sloan Kettering Cancer Center

High prevalence of somatic MAP2K1 mutations in BRAF V600E–negative Langerhans cell histiocytosis

Radioulnar Synostosis-Hematology (RUS-H) Syndrome: Description of the New Syndrome and Comparison to Similar Syndromes

High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses

BRAF mutation: supporting diversity in HCL

Frequent BRAF V600E Mutations Are Identified in CD207+ Cells in LCH Lesions, but BRAF Status does not Correlate with Clinical Presentation of Patients or Transcriptional Profiles of CD207+ Cells

Kinase-Inactivating Braf Mutation Drives Aneuploidy In Splenic Myeloid Cells by Deregulation of Craf

Recurrent BRAF mutations in Langerhans cell histiocytosis

BRAF Mutations in Juvenile Myelomonocytic Leukemia.

Role of BRAF Mutations in Hematopoietic Malignancies and the Induction of Cytokine-Independence-Synergy with PI3K/Akt Pathway.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only